Argus Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock

Cardinal Health (NYSE:CAH) had its price objective raised by investment analysts at Argus from $211.00 to $232.00 in a research report issued on Friday,MarketScreener reports. The firm presently has a “buy” rating on the stock. Argus’ price objective would indicate a potential upside of 11.39% from the stock’s current price.

Several other research firms have also weighed in on CAH. TD Cowen lifted their price objective on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Leerink Partners set a $240.00 price objective on shares of Cardinal Health in a research report on Tuesday, January 13th. Robert W. Baird set a $250.00 target price on shares of Cardinal Health in a research report on Wednesday, January 14th. Finally, Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Fourteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $221.07.

Cardinal Health Trading Up 0.7%

Shares of CAH stock opened at $208.29 on Friday. Cardinal Health has a 1-year low of $120.72 and a 1-year high of $215.48. The stock has a market cap of $49.49 billion, a price-to-earnings ratio of 31.42, a PEG ratio of 1.41 and a beta of 0.65. The stock has a 50-day moving average of $205.78 and a 200-day moving average of $176.26.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the previous year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts forecast that Cardinal Health will post 7.95 earnings per share for the current year.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently bought and sold shares of CAH. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $25,000. SJS Investment Consulting Inc. boosted its holdings in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the period. Atlantic Edge Private Wealth Management LLC grew its stake in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares in the last quarter. Barnes Dennig Private Wealth Management LLC grew its stake in Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after buying an additional 53 shares in the last quarter. Finally, JPL Wealth Management LLC bought a new stake in Cardinal Health during the 3rd quarter valued at $31,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.